NRIX

Nurix Therapeutics, Inc.NASDAQHealthcare

$15.51+0.19%ClosedMarket Cap: $1.34B

As of 2026-04-06

Recent Analyst Ratings

Date	Firm	Action	Rating	Previous
2026-03-24	HC Wainwright & Co.	—	Buy	—
2026-01-29	Wells Fargo	—	Overweight	—
2026-01-29	Needham	—	Buy	—
2026-01-29	Stifel	—	Buy	—
2026-01-29	RBC Capital	—	Outperform	—
2026-01-29	Piper Sandler	—	Overweight	—
2026-01-29	BTIG	—	Buy	—
2026-01-29	HC Wainwright & Co.	—	Buy	—
2026-01-08	Morgan Stanley	—	Overweight	—
2025-12-16	Wells Fargo	—	Overweight	—

Forward Estimates

Period	EPS Est.	Revenue Est.	# Analysts
Tue Nov 30	$-3.00	$72.8M	9
Thu Nov 30	$-2.51	$114.6M	10
Fri Nov 30	$-1.92	$241.7M	4
Sat Nov 30	$-0.35	$492.7M	4